6505-01-346-2062 ( F91G489 , NDC00074-3401-02 , ADD-VANTAGE )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-346-2062 | 6505 | 013462062 | GENTAMICIN SULFATE INJECTION,USP | 3057 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 8.000 MILLILITERS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 80.000 MILLIGRAMS GENTAMICIN SULFATE EQUIVALENT |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 50 |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| F91G489 | 66735 | A | 1 | 5 | 4 | KX | |
| NDC00074-3401-02 | 60060 | A | 2 | 3 | 4 | KX | |
| ADD-VANTAGE | 60060 | A | 1 | 5 | 4 | KX |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| F91G489 | 66735 | AIR FORCE MEDICAL LOGISTICS OFFI | A | A |
| NDC00074-3401-02 | 60060 | ABBOTT LABORATORIES INC. | A | A |
| ADD-VANTAGE | 60060 | ABBOTT LABORATORIES INC. | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 09/28/1 | P | 3004200060 | 3057 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DN | 9L----- | N | K | U/I CONTAINS 50 EA | |
| DN | 9L----- | N | V | DISCONTINUED W/O REPLACEMENT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | S9M | Y | 1 | PG | Q | U | 9L----- | N |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|